Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SeeFar is a digital health company specializing in assistive technology for individuals with severe vision impairments, particularly those suffering from age-related macular degeneration (AMD) and diabetic retinopathy. The company develops smart glasses that utilize augmented reality (AR) and virtual reality (VR) to enhance the remaining vision of users by projecting real-time, processed images onto the retina. Their solution aims to restore independence by assisting with daily tasks such as reading, recognizing faces, and navigating environments. SeeFar's technology integrates advanced image processing algorithms with wearable hardware to provide a non-invasive alternative for vision rehabilitation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seefar.